Mirum Pharmaceuticals, Inc. ($MIRM)
Filing Information
| Accession Number | 0001650131-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
76,955
Total Value
$1,519,015.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT AND COO | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 7,220 | โ | โ | 33,787 | Direct | โ | View Details | |
PRESIDENT AND COO | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 23,000 | โ | โ | 56,787 | Direct | โ | View Details | |
PRESIDENT AND COO | Common Stock | โ | Mar 16, 2026 | Sale | 16,515 | $91.98 | $1,519,015.02 | 40,272 | Direct | โ | View Details | |
PRESIDENT AND COO | Performance Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 7,220 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
PRESIDENT AND COO | Performance Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 23,000 | $0.00 | $0.00 | 11,500 | Direct | โ | View Details |